Relapsing Polychondritis
11 clinical trials · Condition
◉ Watch Relapsing Polychondritis
| Record | Firm | Date |
|---|---|---|
| Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis (NCT05168475) | Cambridge University Hospitals NHS Foundation Trust | 2021-07-14 |
| Longitudinal Study for Relapsing Polychondritis (NCT04919538) | University of Pennsylvania | 2021-02-26 |
| Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis (NCT04077736) | Peking University People's Hospital | 2019-11-01 |
| Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis (NCT02257866) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2014-09-29 |
| Study on the Safety of Abatacept in Relapsing Polychondritis (NCT01272856) | Benaroya Research Institute | 2011-01-01 |
| Tocilizumab for Relapsing Polychondritis (NCT01104480) | McMaster Children's Hospital | 2010-05-01 |
| Single Patient Study to Treat Relapsing Polychondritis With Tocilizumab (NCT01041248) | Children's Hospital of Eastern Ontario | 2010-01-01 |
Track Relapsing Polychondritis automatically
Every clearance here is in the API, with alerts when new ones post.